Ledger.Open graph →
SEC Form D · filed June 23, 2020

Oisin Biotechnologies, Inc

Offering
$5.0M
Sold
$2.1M
Exemption
Rule 506(b)
Industry
Other
Location
SEATTLE, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Matthew Scholz · Seattle, WAExec · DirectorGary Hudson · Seattle, WAExec · DirectorDavid Gobel · Seattle, WADirectorSteve Hilbert · Seattle, WAExecJohn Lewis · Grand Cayman, Cayman IslandsExecEric Garcia · Seattle, WAExecCasey Gard · Bal Harbour, FLExec · DirectorArena Capital Advisors LLC Arena Capital Advisors Arena Capital Advisors LLC · Los Angelea, CADirectorRebeca Minguela · Madrid, U3Exec · DirectorJohn Lewis · Cayman Islands, Cayman IslandsExecJoseph Gits · Chicago, ILExec · DirectorStephen Jouzapaitis · Chicago, ILDirectorChad Eisenberg · Chicago, ILExec · DirectorSteve Hilbert · Seattle, WAExecJohn Lewis · Edmonton, Alberta, CanadaExecEric Garcia · San Francisco, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗